Page 5 - Advanced Ovarian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Role of Biomarkers in Advanced Ovarian Cancer

Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.

Advanced ovarian cancer treatmentRecent updatesLater line maintenance settingsAdvanced ovarianAdvanced ovarian cancerEpithelial ovarian cancerGermline mutationsBiomarker testingTumor testingParp inhibitorsCa 125Genomic instability scoreLoss of heterozygosityMsi highHomologous recombination deficiency

Overview of Advanced Ovarian Cancer

Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide an overview of advanced ovarian cancer and discuss its prevalence and diagnosis process.

Robertl colemanAdvanced ovarian cancer treatmentRecent updatesLater line maintenance settingsAdvanced ovarianBradleyj monkAdvanced ovarian cancerEpithelial ovarian cancerHigh grade serous cancerClear cellGermline mutations

Role of PARP Inhibitors in Advanced Ovarian Cancer

Expert oncologists give an overview of PARP inhibitors available for the treatment of patients with advanced ovarian cancer and review adverse events seen with each agent.

Advanced ovarian cancer treatmentRecent updatesLater line maintenance settingsAdvanced ovarianAdvanced ovarian cancerHomologous recombination deficiencyParp sensitivityParp inhibitionGenomic instability scoreGenomic scarringAdverse events

IMFINZI® (durvalumab) plus LYNPARZA® (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy

IMFINZI® (durvalumab) plus LYNPARZA® (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBrendan mcevoyImfinziand lynparzaasSusan galbraithChelsea fordImfinziand lynparzacombinationShannonn westinUs electronic health recordsUniversity of texas md anderson cancer centerMerck co incWorld cancer research fund internationalAmerican cancer societyInternational journal of gynecological pathologyWall streetGynecologic oncology

ASCO 2023: Integra Connect to Showcase how its Technology and Real-World Data are Helping Deliver on the Promise of Value-based, Precision Oncology

/PRNewswire/ Integra Connect, LLC., the leading provider of value-based, precision medicine solutions and services for specialty care, today announced that.

United statesParpi monotherapyJeffreya scottAlyssa howertonGarret hamptonAmerican society of clinical oncologyPromising tool for community practicesIntegra connectEquality initiativeHealth services researchPopulation health solutions at integraThermo fisherClinical oncologyAnnual meetingThermo fisher scientificTesting advances precision oncology